Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf$ .
: % , " " ,.
" : % " :$ , & , " " : & % . @ , 3 , % " % , 3 .
" & :
1.*6 250 0,5 100
2.* š + + +' 25
3.* 5 ,
4.*+ V
5.*$ 5%, 10% 400 , 500 ; 40% 5 , 10
6.*@ . 60000 - 400
7.* 400 ,
8.*? & 5%, 10%, 20%
9.*6 10 ; 2
10.*+ V 0,05% 1 ; 15
11.* , " , $# &
12.*_ 40 V 20
13.*_ 40
14.*? V 2,4% 5 , 10
" & & :
|
,- !: @ % " % " |
% |
. |
/ , & :
1.Mergener K., Baillie J. Acute pancreatitis. Clinical review. BMJ 1998;316: 44-48;
2.National Guideline Clearinghouse. Treatment of acute pancreatitis;
3.EBM Guidelines. Acute pancreatitis and chronic pancreatitis. 2004.
* – , # (% % ) .
" $
: 21-173
"$ &: " : ( " & )
& ! : , "( , ), % % ,, " .
' & & ( ): 16
(: S82.2 [ ] & S82.3 & & B$" : [ & ] % (S82.5)
) : " $ –& & " .$ : ( ? )
1.( );
2.) .
:
1." ;
2.;
3.;
4.& ;
5.&" ( );
* : &, % % , " .
" |
: 3 |
|
: |
1.< " [1];
2. |
B " |
( , , .) [1]; |
3. |
|
& |
" [1]; |
|
4." % & ;
5." [1];
" & :
1. " 2-
2.7
3.# (6 )
4.# "
6.<
7.! "
8.'BL
9.HbsAg, Anti-HCV.
" & & :
+ :
& " & . "$ :
1. # ( " % ); 2. " & , % " ;
3.% ;
4.! .
" :
1.$# &$ $
2.B $# ;
3.B ;
4..
! " " & $ " .
$ , " " 6 . H & 60
% & |
% . ' " 1 |
|
||||||||
& & " " " &. |
|
|
|
|||||||
' |
|
: |
|
|
|
|
||||
' " 3- |
|
|
% , |
|||||||
" , % " & % , V |
|
|||||||||
& . H % |
& |
|||||||||
% " & & . |
|
|
|
|
|
|
||||
' $ % " & % |
& |
|
||||||||
|
" 6-8 . " & |
|||||||||
|
& |
|
" . |
|
||||||
|
|
|
|
% # |
|
|
||||
% . & , " |
|
|||||||||
& |
" & |
& - & % . % & 3 [3]:
1.% % 1 ., " .
2.% % 1 % % % # " & # .
3.J$ , % %
|
% # " . |
|||||
1-2 |
( |
|||||
% & |
), % & . |
|||||
@ |
|
|
|
3 & "$ , $# |
||
& . |
|
|
||||
! : |
|
|
||||
1. |
1-2 |
– |
3-4 |
\ 1,0-2,0; |
||
2. |
3 |
– |
3-4 |
\ 1,0-2,0 " 12 " (2 |
||
|
) 7 + 100 . / " 8 " (3 ) 3-5 . |
" & :
1. |
*6 250 0,5 100 |
|
2. |
*/ |
V 250 , 500 , 1 000 |
|
|
|
3. |
*/ V 1000 |
|
" & & : |
||
,- ! : |
||
|
1. & |
" " 1- |
3, 6-8, 10-12 & ;
2.! & & " 5 ;
3.' % & ;
4.' % & % ;
5.' " ;
6.% " .
/, & :
1.EBM Guidelines. Fracture of the Leg.- 2001
2.@ & . JB+BL>! B> > 6>+@?/BB $#" .- 6 , « -6 ».- 2002.- .523-524
3.National Guideline Clearinghouse. Practice Managment for Prophylactic Antibiotic Use in Open Fracture: Eastern Association for the Surgery of Trauma.- 2000.- p.28
4.G . " .- 6 , « -6 ».- 2002.- .576- 577
5.National Guideline Clearinghouse. Preoperative Test: the Use of Routine Preoperative Tests for Elective Surgery: Evidence, Methods&Guidance. London.-NICE.- 2003. 108p.
* – , # (% % ) .
" $ -
: 21-171
"$ &: " :
& ! : " # ,
" |
|
( , |
), |
|
% |
% , |
|
|
, |
|
|
" .
' & & ( ): 9
(: S42.3 ( ) "
) :
( ) " # – " & " .
$ : " , ?
1.( );
2.) .
:
1." ;
2.;
3.;
4.& ;
5.&" ( );# :
1.;
2.;
3.;
4..
* : &, % % , " " : 3
:
1.< " ;
2." % " ;
3. |
B " |
( , , .); |
||
4. |
|
& |
" |
% &, |
|
|
" " ; |
5." " # ;
" & |
: |
1. " |
" 2 |
2.7
3.#
4.# "
6.< "
7.! "
8.'BL
9.HbsAg, Anti-HCV.
$# $#
" & & :
+ |
: |
|
|
J$ " |
. |
||
" : |
|||
1. |
$ |
% % . |
|
|
" : |
|
|
|
% |
; |
# 10¤.
2. B $# "& " $ 6 &, % # /B;% .
3. " " % & . K % & " .
4.L 2-3 # " . L 6 & " & % " .
5." & " $ .
" : |
& |
: |
|
|
|
||||
1. |
|
|
|
|
|
|
, |
||
$# . |
|
|
|
|
|
|
|||
2. |
) |
. |
|||||||
|
|
" |
|
|
|
& |
|||
" [2]. |
|
|
|
|
|
|
|||
& |
|
, |
" |
& |
|||||
|
" & & |
- & % [3]. % & 3[3]:
1.% % 1 ., " .
2.% % 1 % % % # " & # .
3.J$ , % % % # " .
1-2 ( % & ), - % & . @
|
|
|
3 |
& |
"$ |
, $# - |
|
& [3]. |
|
|
|||||
! [3]: |
|
|
|||||
1. |
1-2 |
– |
3-4 |
\ 1,0-2,0; |
|||
2. |
3 |
– |
3-4 |
\ 1,0-2,0 " 12 " (2 |
|||
) 7 + 100 . / " 8 " (3 ) 3-5 . |
|||||||
" & : |
|
|
|||||
1. |
*6 250 0,5 100 |
||||||
2. |
*/ V 250 , 500 , 1 000 |
||||||
|
|
|
|
|
|
|
|
3. |
*/ |
|
V 1000 |
||||
" & & : |
|
||||||
|
,- ! : |
|
|
||||
|
& |
" " 1 |
$;
! & & " 2 ;
|
' % & " " " 2-3 |
|
; |
' % & % " 6 & ; |
' " ;
% " .
/ , & :
1.Work Loss Data Institute. Shoulder.- 2005.- 137 p.
2.@ & . JB+BL>! B> > 6>+@?/BB $#" .- 6 , « -6 ».- 2002.- .523-524
3.National Guideline Clearinghouse. Practice Managment for Prophylactic Antibiotic Use in Open Fracture: Eastern Association for the Surgery of Trauma.- 2000.- p.28
4.G . " .- 6 , « -6 ».- 2002.- .576-577
5.National Guideline Clearinghouse. Preoperative Test: the Use of Routine Preoperative Tests for Elective Surgery: Evidence, Methods&Guidance. London.-NICE.- 2003. 108p.
* – , # (% % ) .
: 21-171 |
|
" 8 |
||||
|
|
|
|
|||
"$ &: " |
|
|
|
|
||
: |
|
|
|
|
||
& ! : |
! |
|
6 % , " , |
|||
|
% |
% , |
, |
|||
" . |
|
|
||||
' & & ( ): 9 |
|
|
|
|||
(: S52.7 6 % |
|
"& |
||||
) : " 8 |
– |
& " |
||||
" . |
|
|
|
|
||
$ : ? |
|
|||||
" (?1.3); |
||||||
|
% : |
|
|
|||
- ) , |
|
|
|
|
|
|
- , |
|
|
|
|
|
|
* : &, % % , " . |
||||||
" |
: 3 |
|
|
|
|
|
|
: |
|
|
|
|
1.< " ;
2. |
" % ; |
3. |
B " ( , , .); |
4." % &, &
;
5.% - " ( , " &
"& );
6." # " ;
" & |
: |
1. " |
" 2 |
2.7
3.#
4.# "
6.< "
7.! "
8.'BL
9.HbsAg, Anti-HCV.
$# $# .
" & & :
+ :
J " - " .: "
. & |
& &$ # " |
2 |
|||||
. & |
|
" |
|||||
" 21 |
, |
|
% " . ? & " |
|
|
||
& |
|
&$ |
" |
2 &. |
|
||
" $ " 8-12 |
# . |
& , " &" & &- & % [3]. % & 3[3]:
1.% % 1 ., " .
2.% % 1 % % % # " & # .
3.J$ , % % % # " .
1-2 |
|
( |
||
% & |
), |
% & . |
||
@ |
|
3 & |
"$ |
, $# |
& . |
|
|
||
! [3]: |
|
|
||
1. |
1-2 |
– |
3-4 |
\ 1,0-2,0; |
2. |
3 |
– |
3-4 |
\ 1,0-2,0 " 12 " (2 |
|
) 7 + 100 . / " 8 " (3 ) 3-5 . |
|||
" & : |
|
|
||
1. |
*6 250 0,5 100 |
|||
2. |
*/ V 250 , 500 , 1 000 |
|||
|
|
|
|
|
3. |
*/ V 1000 |
|||
" & & : |
|
|||
,- ! : |
|
|
||
|
& " ; |
|||
|
) % " % ; |
% " .
/ , & :
1.@ & . JB+BL>! B> > 6>+@?/BB $# " .- 6 , «-6 ».- 2002.- .523-524
2.National Guideline Clearinghouse. Elbow. Work Loss Data Institute.- 2004.- p.110
3.National Guideline Clearinghouse. Practice Managment for Prophylactic Antibiotic Use in Open Fracture: Eastern Association for the Surgery of Trauma.- 2000.- p.28
4.National Guideline Clearinghouse. Preoperative Test: the Use of Routine Preoperative Tests for Elective Surgery: Evidence, Methods&Guidance. London.-NICE.- 2003. 108p.
* – , # (% % ) .
|
|
" & |
|
|
|||||
: 21-171 |
|
|
|
|
|
|
|
||
"$ &: " |
|
|
|
|
|
|
|
||
: ( " & ) |
|
|
|
||||||
& |
! : ! |
|
|
|
|
"& , |
|
||
" , |
|
% % , |
|
|
|||||
, " . |
|
|
|
|
|||||
' & & ( ): 8 |
|
|
|
|
|
||||
(: |
|
|
|
|
|
|
|
||
S52.2 |
[ ] |
|
|
|
|
|
|||
S52.4 |
! " " |
|
|
|
|||||
S52.3 |
[ ] " |
|
|
|
|
|
|||
) |
: |
|
|
|
|
|
|
|
|
( ) |
"& # – |
||||||||
|
" & " . |
|
|||||||
$ : |
|
|
|
|
|||||
|
"& . |
|
|
|
|
|
|
|
1.( );
2.) .
:
1." ;
2.;
3.;
4.& ;
5.&" ( );# :
1.;
2.;
3.;
4..
* : &, % % , " .
" |
: 3 |
|
: |
1.< ;
2." % " ;
3. |
B " |
( , , .); |
|
4. |
& " |
% &, |
|
|
" |
|
"& ; |
5." "& # ;
" & |
: |
1. " |
" 2 |
2.7
3.#
4.# "
6.< "
7.! "
8.'BL
9.HbsAg, Anti-HCV.
" & & :
+ : # , &" : " .